Slc1A7 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
Slc1A7 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [@ref1999]
<div class="infobox infobox-gene"> [@ref2000]
SLC1A7 [@ref2001]
Solute Carrier Family 1 Member 7 (EAAT5)
| | | [@ref2001a] |---|---| [@ref2003] | Symbol | SLC1A7 | | Full Name | Solute Carrier Family 1 Member 7 (EAAT5) | | Chromosome | 14p22.1 | | NCBI Gene ID | [6513](https://www.ncbi.nlm.nih.gov/gene/6513) | | OMIM | [604517](https://www.omim.org/entry/604517) | | Ensembl ID | [ENSG00000100124](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000100124) | | UniProt ID | [O43510](https://www.uniprot.org/uniprot/O43510) | | Encoded Protein | [EAAT5](/proteins/eaat5-protein) | | Associated Diseases | [Retinal Degeneration](/diseases/retinal-degeneration), [Glutamate Excitotoxicity](/diseases/neurodegeneration), [Neurodegeneration](/diseases/neurodegeneration) |
</div>
Function
...
SLC1A7 Gene
Overview
Slc1A7 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
Slc1A7 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [@ref1999]
<div class="infobox infobox-gene"> [@ref2000]
SLC1A7 [@ref2001]
Solute Carrier Family 1 Member 7 (EAAT5)
| | | [@ref2001a] |---|---| [@ref2003] | Symbol | SLC1A7 | | Full Name | Solute Carrier Family 1 Member 7 (EAAT5) | | Chromosome | 14p22.1 | | NCBI Gene ID | [6513](https://www.ncbi.nlm.nih.gov/gene/6513) | | OMIM | [604517](https://www.omim.org/entry/604517) | | Ensembl ID | [ENSG00000100124](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000100124) | | UniProt ID | [O43510](https://www.uniprot.org/uniprot/O43510) | | Encoded Protein | [EAAT5](/proteins/eaat5-protein) | | Associated Diseases | [Retinal Degeneration](/diseases/retinal-degeneration), [Glutamate Excitotoxicity](/diseases/neurodegeneration), [Neurodegeneration](/diseases/neurodegeneration) |
</div>
Function
The SLC1A7 gene encodes the excitatory amino acid transporter 5 (EAAT5), the least characterized member of the EAAT family. EAAT5 functions as a high-affinity sodium-dependent glutamate and aspartate transporter, primarily expressed in the retina and sensory [neurons](/entities/neurons).
EAAT5 has a distinctive dual function: it acts as a glutamate transporter and as an anion channel. The transporter component clears glutamate from the synaptic cleft, while the channel component (activated by glutamate binding) allows chloride influx that can modulate the membrane potential. This unique property suggests EAAT5 may function as both a glutamate sensor and a transporter.
In the retina, EAAT5 is critical for maintaining proper visual signal transduction by regulating glutamate levels in the photoreceptor-bipolar cell synapse. Dysfunction of EAAT5 has been implicated in retinal degeneration and may contribute to neurodegenerative processes in other brain regions.
In the retina, EAAT5 is expressed in photoreceptor terminals and bipolar cell dendrites, positioning it ideally to regulate glutamate signaling in the visual pathway.
Slc1A7 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Background
The study of Slc1A7 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.